S. 5316 is a bill that seeks to amend the Defense Production Act of 1950 by expanding the definitions of 'prohibited technology' and 'notifiable technology' to include biotechnology. This means that certain biotechnology-related technologies would be subject to the same regulatory scrutiny as other technologies deemed critical to national security.
Supporters of S. 5316 argue that including biotechnology in the definitions of prohibited and notifiable technologies is essential for safeguarding national security and ensuring that sensitive biotechnological advancements do not fall into the wrong hands. They highlight the growing importance of biotechnology in various sectors and the need for robust oversight.
Critics of S. 5316 express concerns that the bill could stifle innovation and hinder scientific research in the biotechnology field. They argue that overly broad definitions might lead to unnecessary regulatory burdens that could slow down progress and limit the United States' competitiveness in global biotechnology markets.
The analysis of Bill S. 5316, which seeks to amend the Defense Production Act to include biotechnology, reveals no direct industry overlaps with the sponsor Pete Ricketts' top donor industries. Ricketts' primary donor base consists of Health Professionals, contributing a substantial $240 million, and Retired individuals, contributing $75 million. While the biotechnology sector may tangentially relate to health professionals, the lack of direct financial ties or PAC contributions from biotechnology firms indicates a low risk of conflict of interest. Voters should be aware that while the health sector is a significant donor, it does not directly influence the specific provisions of this bill, thus minimizing potential biases.
Top industries funding Pete Ricketts, ranked by total contributions.
Source: OpenSecrets.org (Center for Responsive Politics)
